Vimentin (EMT Marker Protein) Score Predicts Resistance to Erlotinib and Radiation Therapy for Patients With Stage III Non-small Cell Lung Cancer on a Prospective Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.069 ◽

2012 ◽

Vol 84 (3) ◽

pp. S24-S25

Author(s):

R.U. Komaki ◽

Y.B. Kim ◽

I.I. Wistuba ◽

X. Tang ◽

R. Meyn ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Marker Protein ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

104: Vimentin (EMT Marker Protein) Score As One of Predictors Resistance to Erlotinib and Radiotherapy for Patients with Stage III Non-Small Cell Lung Cancer on A Prospective Phase II Trial

Radiotherapy and Oncology ◽

10.1016/s0167-8140(15)34125-6 ◽

2014 ◽

Vol 110 ◽

pp. S51-S52

Author(s):

R. Komaki ◽

Y.B. Kim ◽

I. Wistuba ◽

X. Tang ◽

R. Meyn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Stage Iii ◽

Marker Protein ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

The Phase II Trial of Erotinib and Radiation Therapy Following Chemoradiation Therapy for Patients With Stage III Non-small Cell Lung Cancer has Shown a Favorable Response Profile

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.284 ◽

2012 ◽

Vol 84 (3) ◽

pp. S68-S69

Author(s):

R.U. Komaki ◽

P.K. Allen ◽

X. Wei ◽

G.R. Blumenschein ◽

I.I. Wistuba ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Chemoradiation Therapy ◽

Small Cell Lung ◽

Response Profile

Download Full-text

401P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Annals of Oncology ◽

10.1016/j.annonc.2020.10.395 ◽

2020 ◽

Vol 31 ◽

pp. S1399-S1400

Author(s):

S. Igawa ◽

R. Noro ◽

K. Kubota ◽

K. Naoki ◽

A. Bessho ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7065 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7065-7065 ◽

Author(s):

M. T. Jaklitsch ◽

L. Gu ◽

D. H. Harpole ◽

T. A. D’Amico ◽

R. J. McKenna ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

Treatment of locally advanced non-small cell lung cancer (NSCLC) with taxol (1-hour infusion, cisplatin, etoposide, and radiation therapy (RT): A phase II trial

Lung Cancer ◽

10.1016/0169-5002(94)94480-6 ◽

1994 ◽

Vol 11 ◽

pp. 182 ◽

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell Lung

Download Full-text

Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO

memo - Magazine of European Medical Oncology ◽

10.1007/s12254-011-0246-7 ◽

2011 ◽

Vol 4 (1) ◽

pp. 31-37

Author(s):

I. Stenger ◽

C. Tomala ◽

M. Pietsch ◽

U. Olgemoeller ◽

W. Koerber ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Pretreated Patients

Download Full-text

A Phase II Trial of Preoperative Concurrent Radiation Therapy and Weekly Paclitaxel/Carboplatin for Patients with Locally Advanced Non–Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.3816/clc.2004.n.019 ◽

2004 ◽

Vol 6 (1) ◽

pp. 33-42 ◽

Author(s):

John D. Hainsworth ◽

James R. Gray ◽

Sharlene Litchy ◽

James D. Bearden ◽

Don W. Shaffer ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Weekly Paclitaxel ◽

Small Cell Lung

Download Full-text

Long-Term Results of a Phase II Trial of Induction Paclitaxel-Carboplatin Followed by Concurrent Radiation Therapy and Weekly Paclitaxel and Consolidation Paclitaxel-Carboplatin in Stage III Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318200e563 ◽

2011 ◽

Vol 6 (1) ◽

pp. 79-85 ◽

Author(s):

Francesc Casas ◽

Núria Viñolas ◽

Ferran Ferrer ◽

Carles Agustí ◽

Marcelo Sanchez ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Long Term Results ◽

Small Cell Lung

Download Full-text

Pemetrexed monotherapy in patients with advanced non-small cell lung cancer who have had prior chemotherapy: A prospective phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19137 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19137-19137

Author(s):

H. Lee ◽

M. Ahn ◽

J. Ahn ◽

J. Kwon ◽

S. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

Prospective Phase

Download Full-text

A prospective phase II trial of carboplatin (CBDCA) and nab-paclitaxel (nabPTX) for advanced non-small cell lung cancer (NSCLC) with interstitial lung disease (ILD)

Annals of Oncology ◽

10.1093/annonc/mdz260.094 ◽

2019 ◽

Vol 30 ◽

pp. v647

Author(s):

T. Harada ◽

H. Asahina ◽

S. Oizumi ◽

K. Takamura ◽

M. Harada ◽

...

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text